| Target | Function | Cell line | References |
| APC | Antiproliferation, proapoptosis, and cell cycle inhibition | CM, HCtASMC, and HCAEC | [21, 41] | BNIP3 | Proapoptosis | H9C2 | [16] | CASP8AP2 | Proapoptosis | HUVEC | [42] | Ctgf | Antiangiogenesis, profibrosis | HL-1, cardiac fibroblast | [43, 44] | Dapk1 | Cell cycle inhibition, proapoptosis, and antimigration | HL-1 | [43] | E2F3 | Cell cycle inhibition, proapoptosis | hPASMC, CM | [45, 46] | EFNA3 | Antiangiogenesis, proapoptosis | CT, HL-1, and HUVEC | [34, 43, 47] | HGF | Proangiogenesis, proproliferation, promigration, and prodifferentiation | HUVEC | [39] | HOXA9 | Antiproliferation | CT | [34] | ISCU | Mitochondrial metabolism progression | H9C2, hPASMC, and hPAEC | [7, 14, 17, 48] | MKP1 | Antiproliferation | hPASMC | [49] | PDK1 | Proapoptosis | HAEC | [15] | Ptp1b | Antiangiogenesis, proapoptosis | HL-1 | [43] | ROD1 | Antidifferentiation (seedless) | HUVEC | [50] | RUNX3 | Antiproliferation, antimigration | HUVEC | [51] | SPRED2 | Antimigration | HASMC, HUVEC | [52] | VEGF | Proangiogenesis, promigration, and proinvasion | HUVEC | [21, 37, 38, 47, 51] |
|
|